In the evening of June 5, 2019, Professor Ming-Wei Wang, Director of the National Center for Drug Screening/Chinese National Compound Library and Dean of School of Pharmacy, Fudan University, met with Mr. Yihai Li, Chairman of Jiangxi Jemincare Group Co., Ltd., who is presently visiting La Jolla, California, U.S.A. They discussed potential opportunities to forge bilateral and multilateral collaborations in drug discovery. Drs. Henry (Hongjun) Ji, Chief Executive Officer of Sorrento Therapeutics, Inc. (NASDAQ: SRNE) and Haibing Guo, Vice President and Head of Global Research and Development of Jiangxi Jemincare Group, participated in the discussion.